Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma

@article{Eigtved2000UseOF,
  title={Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma},
  author={Annika Eigtved and Anders P. Andersson and Karin Dahlstr\om and Alan Rab\ol and Mikael Kryger Jensen and S\oren Holm and Sven S\olvsten S\orensen and Krzysztof Tadeusz Drzewiecki and Liselotte H\ojgaard and Lars Friberg},
  journal={European Journal of Nuclear Medicine},
  year={2000},
  volume={27},
  pages={70-75}
}
Correct staging is crucial for the management and prognosis of patients with malignant melanoma. The aim of this prospective study was to compare staging by whole-body positron emission tomography using fluorine-18 fluorodeoxyglucose (18F-FDG) with staging by conventional methods. Thirty-eight patients with malignant melanoma of clinical stage II (local recurrence, in-transit and regional lymph node metastases) or III (metastases to other sites than in stage II) were included in the study. The… CONTINUE READING
30 Citations
27 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 30 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Cost - effectiveness of whole - body PET imaging in non - small cell lung cancer and malignant melanoma

  • GK vonSchulthess, HC Steinert, R Dummer, W Weder
  • Acta Radiol
  • 1998

The mechanism of accumulation of tumor - localising radiopharmaceuticals

  • Pauwels EKJ, R McCready, Stoot JHMB, van Deurzen DFP
  • Eur J Nucl Med
  • 1998

Prospective study of the incidence of melanoma in the Paris region in 1994 . The PETRI Melanoma Group

  • M Baccard, S Havrd, M Souques
  • Melanoma Res
  • 1997

Similar Papers

Loading similar papers…